Page last updated: 2024-11-05

2,4-thiazolidinedione and Atrial Fibrillation

2,4-thiazolidinedione has been researched along with Atrial Fibrillation in 2 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, Z1
Zhang, X1
Korantzopoulos, P1
Letsas, KP1
Tse, G1
Gong, M1
Meng, L1
Li, G1
Liu, T1
Anglade, MW1
Kluger, J1
White, CM1
Aberle, J1
Coleman, CI1

Reviews

1 review available for 2,4-thiazolidinedione and Atrial Fibrillation

ArticleYear
Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis.
    BMC cardiovascular disorders, 2017, 04-05, Volume: 17, Issue:1

    Topics: Atrial Fibrillation; Diabetes Mellitus; Global Health; Humans; Hypoglycemic Agents; Incidence; Ligan

2017

Trials

1 trial available for 2,4-thiazolidinedione and Atrial Fibrillation

ArticleYear
Thiazolidinedione use and post-operative atrial fibrillation: a US nested case-control study.
    Current medical research and opinion, 2007, Volume: 23, Issue:11

    Topics: Aged; Atrial Fibrillation; Case-Control Studies; Double-Blind Method; Female; Humans; Male; Middle A

2007